We previously reported that the RLR agonist Poly(I:C) enhanced radiosensitivity and that cotreatment with Poly(I:C) and IR more than additively increased cell death in human lung adenocarcinoma cells [15]. The gene discussed is DHX58; the disease is lung adenocarcinoma.